Skip to main content
Log in

Cost-of-Illness Studies

A Major Headache?

  • Guest Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Black DAK, Pole JD. Priorities for medical research: indices of burden. British Journal of Social and Preventative Medicine 29: 222–227, 1975

    CAS  Google Scholar 

  • Blau N, Drummond MF. Migraine. Office of Health Economics, London, 1991

    Google Scholar 

  • Commonwealth of Australia. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Department of Health, Housing and Community Services, Woden, A.C.T., 1990

    Google Scholar 

  • Davies LM, Drummond MF. The economic burden of schizophrenia. Psychiatric Bulletin 14: 522–525, 1990

    Article  Google Scholar 

  • Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK. Economic burden of treated benign prostatic hyperplasia in the United Kingdom. British Journal of Urology, in press, 1992

    Google Scholar 

  • Evans RG. We have seen the future and they is us: health care and the greying of Canada. Discussion Paper no. 84-92, Department of Economics, University of British Columbia, Vancouver, 1984

    Google Scholar 

  • Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease and stroke: a comparative analysis. American Journal of Public Health 70: 1249–1260, 1980

    Article  PubMed  CAS  Google Scholar 

  • Henry D. Economic analysis as an aid to subsidisation: the development of Australian guidelines for Pharmaceuticals. PharmacoEconomics 1: 54–67, 1992

    Article  PubMed  CAS  Google Scholar 

  • Jones-Lee MW. The value of life: an economic analysis. Martin Robertson, London, 1976

    Google Scholar 

  • Koopmanschap MA, Van Ineveld BM. Towards a new approach for estimating indirect costs of disease. Social Science and Medicine 34: 1005–1010, 1992

    Article  PubMed  CAS  Google Scholar 

  • Ontario Ministry of Health. Guidelines for preparation of economic analysis to be included in submission to drug programs branch for listing in the Ontario drug benefit formulary/comparative drug index. Toronto, Ministry of Health, 1991

    Google Scholar 

  • Osterhaus JT, Gutterman DL, Plachetka JR. Health care resource and lost labour costs of migraine headache in the US. PharmacoEconomics 2: 67–76, 1992

    Article  PubMed  CAS  Google Scholar 

  • Rice DP. Estimating the cost of illness. Health Economics Series No. 6, Public Health Service, US Government Printing Office, Washington, DC, 1966

    Google Scholar 

  • STG. The impact of AIDS guidelines. The Hague, STG, (Steering Group on Health Technology), 1989

    Google Scholar 

  • Scitovsky AA, Rice DP. Estimates of the direct and indirect costs of Acquired Immunodeficiency Syndrome in the US 1985, 1986 and 1991. Public Health Reports 102: 5–17, 1987

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drummond, M. Cost-of-Illness Studies. Pharmacoeconomics 2, 1–4 (1992). https://doi.org/10.2165/00019053-199202010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199202010-00001

Navigation